Speaker illustration

Doctor Julia Moser

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

Event: EHRA 2022

Topic: Oral Anticoagulation

Session: What is new on stroke prevention

Thumbnail

Which factors are associated with acute pacemaker implantation after ablation of atrial fibrillation?

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation ablation

Thumbnail

Sedation monitoring with processed electroencephalogram signals under propofol sedation: a potential benefit on mapping and catheter ablation of ventricular premature contractions

Event: ESC Congress 2017

Topic: Ventricular arrhythmias

Session: Ventricular arrhythmias

Thumbnail

Influencing factors of in-hospital pacemaker implantation after ablation of AV-nodal reentry- and AV-reentry tachycardia: results from the german ablation registry

Event: ESC Congress 2017

Topic: Supraventricular arrhythmias (excluding AF)

Session: Supraventricular arrhythmias

Thumbnail

Factors associated with acute pacemaker implantation after carvotricuspidal isthmus ablation - results from the german ablation registry

Event: ESC Congress 2017

Topic: Supraventricular arrhythmias (excluding AF)

Session: Supraventricular arrhythmias

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb